335 related articles for article (PubMed ID: 19758643)
1. Editorial comment.
Makarov DV
J Urol; 2009 Nov; 182(5):2255-6. PubMed ID: 19758643
[No Abstract] [Full Text] [Related]
2. Editorial comment.
Naselli A
J Urol; 2009 Nov; 182(5):2256. PubMed ID: 19758664
[No Abstract] [Full Text] [Related]
3. Editorial comment.
Nguyen PL
J Urol; 2010 Mar; 183(3):989. PubMed ID: 20083273
[No Abstract] [Full Text] [Related]
4. Editorial comment.
Moul JW
Urology; 2010 Feb; 75(2):445-6; author reply 446. PubMed ID: 20152507
[No Abstract] [Full Text] [Related]
5. Editorial comment.
Slawin KM
Urology; 2010 Feb; 75(2):444-5; author reply 445. PubMed ID: 20152505
[No Abstract] [Full Text] [Related]
6. Editorial comment.
Carter HB
Urology; 2009 Sep; 74(3):658; author reply 659. PubMed ID: 19716923
[No Abstract] [Full Text] [Related]
7. Editorial comment.
Epstein JI
J Urol; 2010 Mar; 183(3):1001. PubMed ID: 20089268
[No Abstract] [Full Text] [Related]
8. Editorial comment.
Vollmer RT
J Urol; 2010 Mar; 183(3):1001-2. PubMed ID: 20089267
[No Abstract] [Full Text] [Related]
9. Editorial comment.
Porter MP
J Urol; 2010 Mar; 183(3):982; discussion 983. PubMed ID: 20083274
[No Abstract] [Full Text] [Related]
10. Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
Greene DR
Eur Urol; 2007 Sep; 52(3):744-5. PubMed ID: 17350749
[No Abstract] [Full Text] [Related]
11. Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
Trpkov K
Eur Urol; 2007 Sep; 52(3):743-4. PubMed ID: 17350751
[No Abstract] [Full Text] [Related]
12. Re: Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen.
McDonald MW
J Urol; 1998 Oct; 160(4):1442. PubMed ID: 9751386
[No Abstract] [Full Text] [Related]
13. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.
Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
J Urol; 2009 Nov; 182(5):2250-5. PubMed ID: 19758614
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
van der Poel HG
Eur Urol; 2008 Mar; 53(3):561-2. PubMed ID: 17683855
[No Abstract] [Full Text] [Related]
15. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.
D'Amico AV; Chen MH
J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151
[No Abstract] [Full Text] [Related]
16. Re: recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen.
Pruthi RS
J Urol; 1998 May; 159(5):1650. PubMed ID: 9554384
[No Abstract] [Full Text] [Related]
17. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
van der Poel HG
Eur Urol; 2009 May; 55(5):1133-4. PubMed ID: 18585847
[No Abstract] [Full Text] [Related]
18. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
Berney DM
Eur Urol; 2009 May; 55(5):1134. PubMed ID: 18585844
[No Abstract] [Full Text] [Related]
19. Editorial comment on: Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy.
Gallina A
Eur Urol; 2007 Oct; 52(4):1065-6. PubMed ID: 17418935
[No Abstract] [Full Text] [Related]
20. Editorial comment.
Mann MJ
J Urol; 2010 Mar; 183(3):1009. PubMed ID: 20092841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
